Corcept Therapeutics (CORT) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Corcept Therapeutics (CORT) over the last 10 years, with Q3 2025 value amounting to $0.16.
- Corcept Therapeutics' EPS (Weighted Average and Diluted) fell 6097.56% to $0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.87, marking a year-over-year decrease of 3095.24%. This contributed to the annual value of $1.23 for FY2024, which is 3099.41% up from last year.
- Per Corcept Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $0.16 for Q3 2025, which was down 6097.56% from $0.29 recorded in Q2 2025.
- Corcept Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at $0.41 for Q3 2024, and its period low was $0.14 during Q4 2022.
- In the last 5 years, Corcept Therapeutics' EPS (Weighted Average and Diluted) had a median value of $0.25 in 2023 and averaged $0.24.
- Per our database at Business Quant, Corcept Therapeutics' EPS (Weighted Average and Diluted) surged by 10000.0% in 2023 and then tumbled by 6097.56% in 2025.
- Quarter analysis of 5 years shows Corcept Therapeutics' EPS (Weighted Average and Diluted) stood at $0.26 in 2021, then plummeted by 46.15% to $0.14 in 2022, then surged by 100.0% to $0.28 in 2023, then dropped by 4.36% to $0.27 in 2024, then crashed by 40.25% to $0.16 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.16 in Q3 2025, compared to $0.29 in Q2 2025 and $0.17 in Q1 2025.